Leuven, Belgium

Hoa Thu Ngo

This inventor holds 1 USPTO granted patent. Top assignee: Thrombogenics Nv. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hoa Thu Ngo. Retrieved from https://idiyas.com/inventor/hoa-thu-ngo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hoa Thu Ngo in Antibody Development

Introduction

Hoa Thu Ngo is an accomplished inventor based in Leuven, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. His work focuses on innovative solutions for treating various diseases, including cancer.

Latest Patents

Hoa Thu Ngo holds a patent for "Anti-PDGF-C antibodies." This invention relates to antibodies that bind to the PDGF-C antigen. These antibodies are capable of inhibiting the binding of PDGF-C to the PDGFRα receptor and preventing PDGFRα activation by PDGF-C. The applications of these antibodies include potential treatments for cancer, showcasing their importance in medical research and therapy.

Career Highlights

Hoa Thu Ngo is associated with Thrombogenics NV, a company known for its focus on innovative therapies. His work at the company has been pivotal in advancing research in the field of antibodies and their applications in medicine. His dedication to innovation has positioned him as a key figure in the biotechnology sector.

Collaborations

Hoa Thu Ngo collaborates with notable colleagues, including Claudia Fromond and Richard Reinier Zwaal. These collaborations enhance the research environment and contribute to the development of groundbreaking therapies.

Conclusion

Hoa Thu Ngo's contributions to antibody development represent a significant advancement in the fight against cancer. His innovative work continues to inspire and pave the way for future research in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…